A5014387700- Medication Adherence and Compliance
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Lung Cancer Diagnosis and Treatment
- Health and Medical Research Impacts
- Diabetes Treatment and Management
- SARS-CoV-2 detection and testing
- Biomedical Ethics and Regulation
- Diabetes Management and Research
- Public Health in Brazil
- Respiratory viral infections research
- Opioid Use Disorder Treatment
- Radiomics and Machine Learning in Medical Imaging
- Urban and Freight Transport Logistics
- Pain Management and Placebo Effect
- Influenza Virus Research Studies
- Healthcare Policy and Management
- Pharmaceutical Practices and Patient Outcomes
- Economic and Financial Impacts of Cancer
- Global Cancer Incidence and Screening
- Lung Cancer Treatments and Mutations
- Pain Management and Opioid Use
- Lung Cancer Research Studies
- Urban Transport and Accessibility
- Chronic Disease Management Strategies
Optum (United States)
2020-2024
Chronic conditions are common and costly for older Americans the health system. Adherence to daily maintenance medications may improve patient lead lower care spending.To identify predictors of adherence quantify associations with utilization spending among adults chronic conditions, we conducted a longitudinal retrospective analysis using OptumLabs Data Warehouse. This database deidentified administrative claims includes medical eligibility information more than 200 million commercial...
Abstract Objective To identify the association between insulin out‐of‐pocket costs (OOPC) and adherence to in Medicare Advantage (MA) patients. Data Sources Study Setting The study is based on Optum Labs Warehouse, a longitudinal, real‐world data asset with de‐identified administrative claims electronic health record data. Design Using descriptive multivariable logistic regression analyses, we identified likelihood of patients diabetes having ≥60 consecutive days an expected fill date actual...
While molecular testing is recommended for symptomatic patients suspected of having coronavirus disease 2019 (COVID-19), limited data are available examining real-world use tests severe acute respiratory syndrome (SARS-CoV-2) and the impact SARS-CoV-2 on patient outcomes. In this retrospective cohort study using de-identified administrative claims in Optum Labs Data Warehouse, we identified 2 groups with ≥1 outpatient a procedure code between January 2021 September 2022. Group 1 had CPT...
Opioid-tolerant only (OTO) medications, such as transmucosal immediate-release fentanyl products and certain extended-release opioid analgesics, require prior tolerance for safe use, patients without may be at increased risk of overdose. Studies using insurance claims have found that many initiating these medications do not appear to tolerant.To measure prevalence in OTO determine whether linked electronic health record (EHR) data contribute evidence data.This retrospective cohort study used...
BACKGROUND: High out-of-pocket costs (OOPCs) for insulin can lead to cost-related nonadherence and poor outcomes, prompting payers limit OOPCs. However, data are scarce on whether OOPCs at policy-relevant levels is associated with improved adherence outcomes. OBJECTIVE: To identify associations between adherence, noninsulin antihyperglycemic (AHG) medication diabetes-related emergency department (ED) visits hospitalizations. METHODS: This retrospective cohort study was conducted using...
"HSR24-170: Utilization of Biomarker Testing and Biomarker-Driven Targeted Therapy Among Patients With Metastatic Non–Small Cell Lung Cancer" published on 05 Apr 2024 by National Comprehensive Cancer Network.
11154 Background: Despite concerted efforts to improve clinical trial participation (CTP), enrollment remains low. Perceived additional costs the patient or health plan may be barriers CTP; low biomarker testing rates another. This study assessed differences in characteristics of patients with CTP versus without an insured population advanced cancer. Methods: A retrospective analysis was conducted using de-identified administrative claims data from commercially and Medicare Advantage (MA)...
Introduction: Cardiovascular disease (CVD) continues to be the leading cause of death in US and globally. Clinical practice guidelines recommend genetic testing for diagnosis select CVDs improve management, reduce incidence cardiac events, positively impact major adverse events. Professional also pharmacogenomic (PGx) patients being prescribed certain medications. Research Question: What is utilization PGx with CVD US? Methods: This study used data from Optum Labs Data Warehouse, composed...
405 Background: With the increased utilization of chest computed tomography, incidental pulmonary nodules (PN) are frequently encountered in clinical practice. While several professional guidelines exist on PN management, limited evidence exists regarding evaluation We examined incidence lung cancer (LC) and invasive procedures patients with PNs using real-world data. Methods: conducted a retrospective cohort study longitudinal, data de-identified administrative claims electronic health...
Introduction: Concerns over cost-related non-adherence and high patient out-of-pocket (OOP) costs for insulin has prompted policies limiting copays. This study examines the associations of OOP cost by policy-relevant groupings, with gaps in therapy dose, expanding on current data. Methods: retrospective cohort included patients from OptumLabs® Data Warehouse, a longitudinal, real-world data asset de-identified administrative claims electronic health record data, commercial insurance, type 1...
Introduction: High patient out-of-pocket (OOP) cost for insulin led to a program limiting OOP $35/30-day supply in select Medicare Part D plans. This study assessed the association between utilization and Advantage (MA) patients with diabetes.Methods: included MA type 1 (T1D) or 2 diabetes (T2D) OptumLabs® Data Warehouse, longitudinal, real-world data asset de-identified administrative claims electronic health record data, from 2006-2018. Index date was January following two prior year....